Skip to main content
Clinical Trials/NCT04314232
NCT04314232
Unknown
Not Applicable

Changes in Organ Specific Biomarkers, Virus Expression and Prognosis of Covid-19

University Hospital, Akershus1 site in 1 country200 target enrollmentMarch 18, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID
Sponsor
University Hospital, Akershus
Enrollment
200
Locations
1
Primary Endpoint
Number of participants with ICU admission or death
Last Updated
5 years ago

Overview

Brief Summary

Covid-19 is associated with a wide range of symptoms and clinical trajectories, and early identification of patients at risk for developing severe disease is desirable. Several risk markers and comorbidity profiles have been proposed but their relative importance in unselected patients admitted to hospital with Covid-19 remains unclear. This study aims to assess the prognostic value organ specific biomarkers, viral dynamics and immune response markers in patients infected with SARS-CoV2.

Registry
clinicaltrials.gov
Start Date
March 18, 2020
End Date
December 31, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Akershus
Responsible Party
Principal Investigator
Principal Investigator

Torbjorn Omland

Professor

University Hospital, Akershus

Eligibility Criteria

Inclusion Criteria

  • All patients \>18 years of age with a positive test for SARS-CoV2 are eligble for inclusion.
  • Healty age-matched volunteers will be included as a control group

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of participants with ICU admission or death

Time Frame: From hospital admission (baseline) until the date of either admission to the ICU or death during the index hospitalization (up to 52 weeks)

Combined outcome measure of either ICU admission or death

Secondary Outcomes

  • Number of participants with ICU admission(From hospital admission (baseline) until the date of admission to the ICU during the index hospitalization (up to 52 weeks))
  • Total duration of hospital stay(From hospital admission (baseline) until hospital discharge or death during the index hospitalization (up to 52 weeks))
  • Total duration of ICU stay(From admission to the ICU until transfer to another ward, discharge from the hospital or death during the index hospitalization (up to 52 weeks))
  • Number of participants with death from all causes(From hospital admission (baseline) unitl the date of death during the index hospitalization (up to 52 weeks))

Study Sites (1)

Loading locations...

Similar Trials